This effect was associated with an mTOR-specific regulation of FANCD2, a member of the Fanconi anemia DNA repair pathway, which was downregulated upon PP242 treatment but not rapamycin treatment (60). The gene discussed is FANCD2; the disease is Fanconi anemia.